NCT00263640 arm group d2a294cfce624862e1adb0f59dc8ba98 [clinicaltrials_resource:NCT00263640/arm-group/d2a294cfce624862e1adb0f59dc8ba98]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00263640 arm group d2a294cfce624862e1adb0f59dc8ba98 [clinicaltrials_resource:NCT00263640/arm-group/d2a294cfce624862e1adb0f59dc8ba98]
Bio2RDF identifier
NCT00263640/arm-group/d2a294cfce624862e1adb0f59dc8ba98
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... a294cfce624862e1adb0f59dc8ba98
description [clinicaltrials_vocabulary:description]
The drug tested in this study ...... njections of increasing doses.
identifier
clinicaltrials_resource:NCT00263640/arm-group/d2a294cfce624862e1adb0f59dc8ba98
title
NCT00263640 arm group d2a294cfce624862e1adb0f59dc8ba98
@en
type
label
NCT00263640 arm group d2a294cf ...... 294cfce624862e1adb0f59dc8ba98]
@en